Fiasp (insulin aspart) is a fast-acting insulin used to control high blood sugar in adults and children with diabetes mellitus. It is designed to act even faster than traditional rapid-acting insulins, making it suitable for injection at the beginning of a meal or within 20 minutes after starting a meal.Who Should Consider Fiasp? Fiasp is suitable for:
- Adults and children with type 1 diabetes.
- Adults with type 2 diabetes who require insulin to manage blood sugar spikes associated with meals.
How is Fiasp Administered?
Fiasp is administered via subcutaneous injection or through an insulin pump. It should be injected at the start of a meal or within 20 minutes after starting to eat. The dosing is individualized based on the patient’s blood sugar monitoring results and their healthcare provider’s recommendations
Important Information for Fiasp Users:
- How to Use: Follow your healthcare provider’s instructions carefully when administering Fiasp. Ensure proper injection technique and rotate injection sites to prevent skin changes such as lipodystrophy.
- Storage: Unopened Fiasp vials, pens, and cartridges should be stored in the refrigerator but not frozen. Opened or in-use vials can be kept at room temperature or in the refrigerator. Pens and cartridges in use should not be refrigerated.
- Side Effects: Common side effects include hypoglycemia, allergic reactions at the injection site, lipodystrophy, and weight gain. Severe side effects can include systemic allergic reactions.
- Monitoring: Regular monitoring of blood glucose levels is essential. Adjustments to insulin dosage should be made based on blood sugar levels and as directed by a healthcare provider.
Medication Warnings
- Hypoglycemia: Fiasp can cause low blood sugar levels (hypoglycemia), which can be severe. Be aware of the symptoms of hypoglycemia, which include shaking, sweating, fast heartbeat, and blurred vision, and know how to treat it promptly.
- Hyperglycemia: If not dosed properly or if a dose is missed, Fiasp can lead to high blood sugar levels (hyperglycemia). Symptoms include excessive thirst, frequent urination, confusion, and drowsiness.
- Potassium Levels: Fiasp may cause a significant shift in potassium levels in the blood, which can lead to hypokalemia, a potentially life-threatening condition.
Who Should and Shouldn’t Take Fiasp?
- Suitable Candidates:
- Individuals requiring fast-acting insulin to manage mealtime blood sugar spikes.
- Unsuitable Candidates:
- Individuals with hypersensitivity to insulin aspart or any of the excipients in Fiasp.
- Patients experiencing hypoglycemia should not take Fiasp until their blood sugar levels are stabilized.
For more detailed information and personalized advice, consult your healthcare provider.
